1. Home
  2. CSTE vs ICCM Comparison

CSTE vs ICCM Comparison

Compare CSTE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.47

Market Cap

68.8M

Sector

Industrials

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.64

Market Cap

43.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
ICCM
Founded
1987
2006
Country
Israel
Israel
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
43.4M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
CSTE
ICCM
Price
$1.47
$0.64
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$2.50
AVG Volume (30 Days)
98.8K
169.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
$1.59
$31.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.54
52 Week High
$3.70
$1.53

Technical Indicators

Market Signals
Indicator
CSTE
ICCM
Relative Strength Index (RSI) 31.92 57.53
Support Level $0.86 $0.59
Resistance Level $1.90 $0.74
Average True Range (ATR) 0.22 0.03
MACD -0.08 0.01
Stochastic Oscillator 14.37 90.25

Price Performance

Historical Comparison
CSTE
ICCM

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: